Vitamin D: A neurosteroid affecting brain development and function; implications for neurological and psychiatric disorders

Vitamin D

Volumn , Issue , 2011, Pages 565-582

  Eyles, Darryl ^a,b   Burne, Thomas ^a,b   McGrath, John ^a,b  

^a QUEENSLAND CENTRE FOR MENTAL HEALTH RESEARCH   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884798453     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-381978-9.10032-0     Document Type: Chapter

References (189)

1. McGrath J., Feron F., Eyles D. Vitamin D: the neglected neurosteroid?. Trends Neurosci. 2001, 24:570-572.
2. Eyles D.W., Smith S., Kinobe R., Hewison M., McGrath J.J. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J. Chem. Neuroanat. 2005, 29:21-30.
3. Garcion E., Wion-Barbot N., Montero-Menei C.N., Berger F., Wion D. New clues about vitamin D functions in the nervous system. Trends Endocrinol. Metab. 2002, 13:100-105.
4. Melcangi R.C., Panzica G. Neuroactive steroids: an update of their roles in central and peripheral nervous system. Psychoneuroendocrinology 2009, 34(Suppl. 1):S1-S8.
5. McCann J.C., Ames B.N. Is there convincing biological or behavioral evidence linking vitamin D deficiency to brain dysfunction?. FASEB J. 2008, 22:982-1001.
6. Stumpf W.E., Sar M., Clark S.A., DeLuca H.F. Brain target sites for 1,25-dihydroxyvitamin D3. Science 1982, 215:1403-1405.
7. Stumpf W.E., O'Brien L.P. Autoradiographic studies with 3H 1,25 dihydroxyvitamin D3 in thyroid and associated tissues of the neck region. Histochemistry 1987, 87:53-58.
8. Bidmon H.J., Mayerhofer A., Heiss C., Bartke A., Stumpf W.E. Vitamin D (Soltriol) receptors in the choroid plexus and ependyma: their species-specific presence. Mol. Cell Neurosci. 1991, 2:145-156.
9. Musiol I.M., Stumpf W.E., Bidmon H.J., Heiss C., Mayerhofer A., Bartke A. Vitamin D nuclear binding to neurons of the septal, substriatal and amygdaloid area in the Siberian hamster (Phodopus sungorus) brain. Neuroscience 1992, 48:841-848.
10. Walters M.R., Fischette C.T., Fetzer C., May B., Riggle P.C., Tibaldo-Bongiorno M., et al. Specific 1,25-dihydroxyvitamin D3 binding sites in choroid plexus. Eur. J. Pharmacol. 1992, 213:309-311.
11. Pardridge W.M., Sakiyama R., Coty W.A. Restricted transport of vitamin D and A derivatives through the rat blood-brain barrier. J. Neurochem. 1985, 44:1138-1141.
12. Prufer K., Jirikowski G.F. 1.25-Dihydroxyvitamin D3 receptor is partly colocalized with oxytocin immunoreactivity in neurons of the male rat hypothalamus. Cell Mol. Biol. (Noisy-le-grand) 1997, 43:543-548.
13. Clemens T.L., McGlade S.A., Garrett K.P., Horiuchi N., Hendy G.N. Tissue-specific regulation of avian vitamin D-dependent calcium-binding protein 28-kDa mRNA by 1,25-dihydroxyvitamin D3. J. Biol. Chem. 1988, 263:13112-13116.
14. Prufer K., Veenstra T.D., Jirikowski G.F., Kumar R. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the rat brain and spinal cord. J. Chem. Neuroanat. 1999, 16:135-145.
15. Walbert T., Jirikowski G.F., Prufer K. Distribution of 1,25-dihydroxyvitamin D3 receptor immunoreactivity in the limbic system of the rat. Horm. Metab. Res. 2001, 33:525-531.
16. Langub M.C., Herman J.P., Malluche H.H., Koszewski N.J. Evidence of functional vitamin D receptors in rat hippocampus. Neuroscience 2001, 104:49-56.
17. Craig T.A., Sommer S., Sussman C.R., Grande J.P., Kumar R. Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio. J. Bone Miner. Res. 2008, 23:1486-1496.
18. Burne T., Scott E., van Swinderen B., Hilliard M., Reinhard J., Claudianos C., et al. Big ideas for small brains: what can psychiatry learn from worms, flies, bees and fish?. Mol. Psychiatry 2010, 1-10.
19. Sutherland M.K., Somerville M.J., Yoong L.K., Bergeron C., Haussler M.R., McLachlan D.R. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels. Brain Res. Mol. Brain Res. 1992, 13:239-250.
20. Moore T.B., Koeffler H.P., Yamashiro J.M., Wada R.K. Vitamin D3 analogs inhibit growth and induce differentiation in LA-N-5 human neuroblastoma cells. Clin. Exp. Metastasis 1996, 14:239-245.
21. Balabanova S., Richter H.P., Antoniadis G., Homoki J., Kremmer N., Hanle J., et al. 25-Hydroxyvitamin D, 24, 25-dihydroxyvitamin D and 1,25-dihydroxyvitamin D in human cerebrospinal fluid. Klin. Wochenschr. 1984, 62:1086-1090.
22. Gascon-Barre M., Huet P.M. Apparent [3H]1,25-dihydroxyvitamin D3 uptake by canine and rodent brain. Am. J. Physiol. 1983, 244:E266-E271.
23. Taylor A.N. Chick brain calcium binding protein: response to cholecalciferol and some developmental aspects. J. Nutr. 1977, 107:480-486.
24. Zehnder D., Bland R., Williams M.C., McNinch R.W., Howie A.J., Stewart P.M., et al. Extrarenal expression of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase. J. Clin. Endocrinol. Metab. 2001, 86:888-894.
25. Fu G.K., Lin D., Zhang M.Y., Bikle D.D., Shackleton C.H., Miller W.L., et al. Cloning of human 25-hydroxyvitamin D-1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type 1. Mol. Endocrinol. 1997, 11:1961-1970.
26. Neveu I., Naveilhan P., Menaa C., Wion D., Brachet P., Garabedian M. Synthesis of 1,25-dihydroxyvitamin D3 by rat brain macrophages in vitro. J. Neurosci. Res. 1994, 38:214-220.
27. Naveilhan P., Neveu I., Baudet C., Ohyama K.Y., Brachet P., Wion D. Expression of 25(OH) vitamin D3 24-hydroxylase gene in glial cells. Neuroreport. 1993, 5:255-257.
28. Stumpf W.E., O'Brien L.P. 1,25 (OH)2 vitamin D3 sites of action in the brain. An autoradiographic study. Histochemistry 1987, 87:393-406.
29. Zou J., Landy H., Feun L., Xu R., Lampidis T., Wu C.J., et al. Correlation of a unique 220-kDa protein with vitamin D sensitivity in glioma cells. Biochem. Pharmacol. 2000, 60:1361-1365.
30. Baas D., Prufer K., Ittel M.E., Kuchler-Bopp S., Labourdette G., Sarlieve L.L., et al. Rat oligodendrocytes express the vitamin D(3) receptor and respond to 1,25-dihydroxyvitamin D(3). Glia 2000, 31:59-68.
31. Mehta R.G., Mehta R.R. Vitamin D and cancer. J. Nutr. Biochem. 2002, 13:252-264.
32. Eyles D., Brown J., Mackay-Sim A., McGrath J., Feron F. Vitamin D3 and brain development. Neuroscience 2003, 118:641-653.
33. Ko P., Burkert R., McGrath J., Eyles D. Maternal vitamin D3 deprivation and the regulation of apoptosis and cell cycle during rat brain development. Brain Res. Dev. Brain Res. 2004, 153:61-68.
34. Johnson J.A., Grande J.P., Windebank A.J., Kumar R. 1,25-Dihydroxyvitamin D(3) receptors in developing dorsal root ganglia of fetal rats. Brain Res. Dev. Brain Res. 1996, 92:120-124.
35. Veenstra T.D., Prufer K., Koenigsberger C., Brimijoin S.W., Grande J.P., Kumar R. 1,25-Dihydroxyvitamin D3 receptors in the central nervous system of the rat embryo. Brain Res. 1998, 804:193-205.
36. Erben R.G., Soegiarto D.W., Weber K., Zeitz U., Lieberherr M., Gniadecki R., et al. Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D. Mol. Endocrinol. 2002, 16:1524-1537.
37. Cui X., McGrath J.J., Burne T.H., Mackay-Sim A., Eyles D.W. Maternal vitamin D depletion alters neurogenesis in the developing rat brain. Int. J. Dev. Neurosci. 2007, 25:227-232.
38. Burkert R., McGrath J., Eyles D. Vitamin D receptor expression in the embryonic rat brain. Neurosci. Res. Comm. 2003, 33:63-71.
39. Burne T.H., Becker A., Brown J., Eyles D.W., Mackay-Sim A., McGrath J.J. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav. Brain Res. 2004, 154:549-555.
40. O'Loan J., Eyles D.W., Kesby J., Ko P., McGrath J.J., Burne T.H. Vitamin D deficiency during various stages of pregnancy in the rat; its impact on development and behaviour in adult offspring. Psychoneuroendocrinology 2007, 32:227-234.
41. Reynolds B.A., Rietze R.L. Neural stem cells and neurospheres - re-evaluating the relationship. Nat. Methods 2005, 2:333-336.
42. Brown J., Bianco J.I., McGrath J.J., Eyles D.W. 1,25-Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neurosci. Lett. 2003, 343:139-143.
43. Marini F., Bartoccini E., Cascianelli G., Voccoli V., Baviglia M.G., Magni M.V., et al. Effect of 1alpha,25-dihydroxyvitamin D3 in embryonic hippocampal cells. Hippocampus 2010, 20:696-705.
44. Feron F., Burne T.H., Brown J., Smith E., McGrath J.J., Mackay-Sim A., et al. Developmental Vitamin D3 deficiency alters the adult rat brain. Brain Res. Bull. 2005, 65:141-148.
45. Eyles D., Almeras L., Benech P., Patatian A., Mackay-Sim A., McGrath J., et al. Developmental vitamin D deficiency alters the expression of genes encoding mitochondrial, cytoskeletal and synaptic proteins in the adult rat brain. J. Steroid Biochem. Mol. Biol. 2007, 103:538-545.
46. Almeras L., Eyles D., Benech P., Laffite D., Villard C., Patatian A., et al. Developmental vitamin D deficiency alters brain protein expression in the adult rat: implications for neuropsychiatric disorders. Proteomics 2007, 7:769-780.
47. McGrath J., Iwazaki T., Eyles D., Burne T., Cui X., Ko P., et al. Protein expression in the nucleus accumbens of rats exposed to developmental vitamin D deficiency. PLoS One 2008, 3:e2383.
48. Keilhoff G., Grecksch G., Becker A. Haloperidol normalized prenatal vitamin D depletion-induced reduction of hippocampal cell proliferation in adult rats. Neurosci. Lett. 2010, 476:94-98.
49. Matkovits T., Christakos S. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation. Mol. Endocrinol. 1995, 9:232-242.
50. Baksi S.N., Hughes M.J. Chronic vitamin D deficiency in the weanling rat alters catecholamine metabolism in the cortex. Brain Res. 1982, 242:387-390.
51. Tenenhouse A., Warner M., Commissiong J.W. Neurotransmitters in the CNS of the vitamin D deficient, hypocalcemic rat. Neurochem. Int. 1991, 18:249-255.
52. Kesby J.P., Cui X., Ko P., McGrath J.J., Burne T.H., Eyles D.W. Developmental vitamin D deficiency alters dopamine turnover in neonatal rat forebrain. Neurosci. Lett. 2009, 461:155-158.
53. Altemus K.L., Finger S., Wolf C., Birge S.J. Behavioral correlates of vitamin D deficiency. Physiol. Behav. 1987, 39:435-440.
54. Burne T.H., Feron F., Brown J., Eyles D.W., McGrath J.J., Mackay-Sim A. Combined prenatal and chronic postnatal vitamin D deficiency in rats impairs prepulse inhibition of acoustic startle. Physiol. Behav. 2004, 81:651-655.
55. Kesby J.P., Burne T.H., McGrath J.J., Eyles D.W. Developmental vitamin D deficiency alters MK 801-induced hyperlocomotion in the adult rat: an animal model of schizophrenia. Biol. Psychiatry 2006, 60:591-596.
56. Burne T.H.J., Becker A., Brown J., Eyles D.W., Mackay-Sim A., McGrath J.J. Transient prenatal Vitamin D deficiency is associated with hyperlocomotion in adult rats. Behav. Brain Res. 2004, 154:549-555.
57. Becker A., Eyles D.W., McGrath J.J., Grecksch G. Transient prenatal vitamin D deficiency is associated with subtle alterations in learning and memory functions in adult rats. Behav. Brain Res. 2005, 161:306-312.
58. Burne T.H.J., McGrath J.J., Mackay-Sim A., Eyles D.W. Prenatal vitamin D deficiency and brain development. Vitamin D: New Research 2006, 153-172. Nova Science Publishers, New York. V.D. Stoltz (Ed.).
59. Burne T.H., O'Loan J., McGrath J.J., Eyles D.W. Hyperlocomotion associated with transient prenatal vitamin D deficiency is ameliorated by acute restraint. Behav. Brain Res. 2006, 174:119-124.
60. Eyles D.W., Rogers F., Buller K., McGrath J.J., Ko P., French K., et al. Developmental vitamin D (DVD) deficiency in the rat alters adult behaviour independently of HPA function. Psychoneuroendocrinology 2006, 31:958-964.
61. J.P. Kesby, X. Cui, J. O'Loan, J.J. McGrath, T.H. Burne, D.W. Eyles. Developmental vitamin D deficiency alters dopamine-mediated behaviors and dopamine transporter function in adult female rats. Psychopharmacology (Berl.) 208 159-168.
62. Sulzer D., Maidment N.T., Rayport S. Amphetamine and other weak bases act to promote reverse transport of dopamine in ventral midbrain neurons. J. Neurochem. 1993, 60:527-535.
63. Becker A., Grecksch G. Pharmacological treatment to augment hole board habituation in prenatal Vitamin D-deficient rats. Behav. Brain Res. 2006, 166:177-183.
64. Grecksch G., Ruthrich H., Hollt V., Becker A. Transient prenatal vitamin D deficiency is associated with changes of synaptic plasticity in the dentate gyrus in adult rats. Psychoneuroendocrinology 2009, 34(Suppl. 1):S258-S264.
65. Harms L.R., Eyles D.W., McGrath J.J., Mackay-Sim A., Burne T.H. Developmental vitamin D deficiency alters adult behaviour in 129/SvJ and C57BL/6J mice. Behav. Brain Res. 2008, 187:343-350.
66. de Abreu D.A., Nivet E., Baril N., Khrestchatisky M., Roman F., Feron F. Developmental vitamin D deficiency alters learning in C57Bl/6J mice. Behav. Brain Res. 2010, 208:603-608.
67. Panda D.K., Miao D., Tremblay M.L., Sirois J., Farookhi R., Hendy G.N., et al. Targeted ablation of the 25-hydroxyvitamin D 1alpha-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc. Natl. Acad. Sci. USA 2001, 98:7498-7503.
68. Dardenne O., Prud'homme J., Arabian A., Glorieux F.H., St-Arnaud R. Targeted inactivation of the 25-hydroxyvitamin D(3)-1(alpha)-hydroxylase gene (CYP27B1) creates an animal model of pseudovitamin D-deficiency rickets. Endocrinology 2001, 142:3135-3141.
69. St-Arnaud R., Dardenne O., Prud'homme J., Hacking S.A., Glorieux F.H. Conventional and tissue-specific inactivation of the 25-hydroxyvitamin D-1alpha-hydroxylase (CYP27B1). J. Cell Biochem. 2003, 88:245-251.
70. Kong J., Li X.J., Gavin D., Jiang Y., Li Y.C. Targeted expression of human vitamin D receptor in the skin promotes the initiation of the postnatal hair follicle cycle and rescues the alopecia in vitamin D receptor null mice. J. Invest. Dermatol. 2002, 118:631-638.
71. Van Cromphaut S.J., Dewerchin M., Hoenderop J.G., Stockmans I., Van Herck E., Kato S., et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc. Natl. Acad. Sci. USA 2001, 98:13324-13329.
72. Yoshizawa T., Handa Y., Uematsu Y., Takeda S., Sekine K., Yoshihara Y., et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat. Genet. 1997, 16:391-396.
73. Li Y.C., Pirro A.E., Amling M., Delling G., Baron R., Bronson R., et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA 1997, 94:9831-9835.
74. Kalueff A.V., Keisala T., Minasyan A., Kuuslahti M., Miettinen S., Tuohimaa P. Behavioural anomalies in mice evoked by "Tokyo" disruption of the Vitamin D receptor gene. Neurosci. Res. 2006, 54:254-260.
75. Bula C.M., Huhtakangas J., Olivera C., Bishop J.E., Norman A.W., Henry H.L. Presence of a truncated form of the vitamin D receptor (VDR) in a strain of VDR-knockout mice. Endocrinology 2005, 146:5581-5586.
76. Kalueff A.V., Lou Y.R., Laaksi I., Tuohimaa P. Impaired motor performance in mice lacking neurosteroid vitamin D receptors. Brain Res. Bull. 2004, 64:25-29.
77. Burne T.H., McGrath J.J., Eyles D.W., Mackay-Sim A. Behavioural characterization of vitamin D receptor knockout mice. Behav. Brain Res. 2005, 157:299-308.
78. Burne T.H., Johnston A.N., McGrath J.J., Mackay-Sim A. Swimming behaviour and post-swimming activity in Vitamin D receptor knockout mice. Brain Res. Bull. 2006, 69:74-78.
79. Kalueff A.V., Lou Y.R., Laaksi I., Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport. 2004, 15:1271-1274.
80. Minasyan A., Keisala T., Lou Y.R., Kalueff A.V., Tuohimaa P. Neophobia, sensory and cognitive functions, and hedonic responses in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 2007, 104:274-280.
81. Keisala T., Minasyan A., Jarvelin U., Wang J., Hamalainen T., Kalueff A.V., et al. Aberrant nest building and prolactin secretion in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 2007, 104:269-273.
82. Minasyan A., Keisala T., Zou J., Zhang Y., Toppila E., Syvala H., et al. Vestibular dysfunction in vitamin D receptor mutant mice. J. Steroid Biochem. Mol. Biol. 2009, 114:161-166.
83. Zou J., Minasyan A., Keisala T., Zhang Y., Wang J.H., Lou Y.R., et al. Progressive hearing loss in mice with a mutated vitamin D receptor gene. Audiol. Neurootol. 2008, 13:219-230.
84. Kalueff A., Loseva E., Haapasalo H., Rantala I., Keranen J., Lou Y.R., et al. Thalamic calcification in vitamin D receptor knockout mice. Neuroreport. 2006, 17:717-721.
85. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 2002, 110:229-238.
86. Xiang W., Kong J., Chen S., Cao L.P., Qiao G., Zheng W., et al. Cardiac hypertrophy in vitamin D receptor knockout mice: role of the systemic and cardiac renin-angiotensin systems. Am. J. Physiol. Endocrinol. Metab. 2005, 288:E125-E132.
87. Tishkoff D.X., Nibbelink K.A., Holmberg K.H., Dandu L., Simpson R.U. Functional vitamin D receptor (VDR) in the t-tubules of cardiac myocytes: VDR knockout cardiomyocyte contractility. Endocrinology 2008, 149:558-564.
88. Wong K.E., Szeto F.L., Zhang W., Ye H., Kong J., Zhang Z., et al. Involvement of the vitamin D receptor in energy metabolism: regulation of uncoupling proteins. Am. J. Physiol. Endocrinol. Metab. 2009, 296:E820-E828.
89. Ceglia L. Vitamin D and skeletal muscle tissue and function. Mol. Aspects Med. 2008, 29:407-414.
90. Ozer S., Ulusahin A., Ulusoy S., Okur H., Coskun T., Tuncali T., et al. Is vitamin D hypothesis for schizophrenia valid? Independent segregation of psychosis in a family with vitamin-D-dependent rickets type IIA. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:255-266.
91. Sanchez B., Relova J.L., Gallego R., Ben-Batalla I., Perez-Fernandez R. 1,25-Dihydroxyvitamin D3 administration to 6-hydroxydopamine-lesioned rats increases glial cell line-derived neurotrophic factor and partially restores tyrosine hydroxylase expression in substantia nigra and striatum. J. Neurosci. Res. 2009, 87:723-732.
92. Wang J.Y., Wu J.N., Cherng T.L., Hoffer B.J., Chen H.H., Borlongan C.V., et al. Vitamin D-3 attenuates 6-hydroxydopamine-induced neurotoxicity in rats. Brain Res. 2001, 904:67-75.
93. Chen K.B., Lin A.M., Chiu T.H. Systemic vitamin D3 attenuated oxidative injuries in the locus coeruleus of rat brain. Ann. N.Y. Acad. Sci. 2003, 993:313-324. Discussion 345-319.
94. Cass W.A., Smith M.P., Peters L.E. Calcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamine. Ann. N.Y. Acad. Sci. 2006, 1074:261-271.
95. Puchacz E., Stumpf W.E., Stachowiak E.K., Stachowiak M.K. Vitamin D increases expression of the tyrosine hydroxylase gene in adrenal medullary cells. Brain Res. Mol. Brain Res. 1996, 36:193-196.
96. Salvatore M.F., Zhang J.L., Large D.M., Wilson P.E., Gash C.R., Thomas T.C., et al. Striatal GDNF administration increases tyrosine hydroxylase phosphorylation in the rat striatum and substantia nigra. J. Neurochem. 2004, 90:245-254.
97. Lin A.M., Fan S.F., Yang D.M., Hsu L.L., Yang C.H. Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic. Biol. Med. 2003, 34:1416-1425.
98. Evatt M.L., Delong M.R., Khazai N., Rosen A., Triche S., Tangpricha V. Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease. Arch. Neurol. 2008, 65:1348-1352.
99. Newmark H.L., Newmark J. Vitamin D and Parkinson's disease - a hypothesis. Movement Disorders 2007, 22:461-468.
100. Kim J.S., Kim Y.I., Song C., Yoon I., Park J.W., Choi Y.B., et al. Association of vitamin D receptor gene polymorphism and Parkinson's disease in Koreans. J. Korean Med. Sci. 2005, 20:495-498.
101. Lemire J.M., Archer D.C. 1,25-Dihydroxyvitamin D3 prevents the in vivo induction of murine experimental autoimmune encephalomyelitis. J. Clin. Invest. 1991, 87:1103-1107.
102. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxyvitamin D3 reversibly blocks the progression of relapsing encephalomyelitis, a model of multiple sclerosis. Proc. Natl. Acad. Sci. USA 1996, 93:7861-7864.
103. Nataf S., Garcion E., Darcy F., Chabannes D., Muller J.Y., Brachet P. 1,25 Dihydroxyvitamin D3 exerts regional effects in the central nervous system during experimental allergic encephalomyelitis. J. Neuropathol. Exp. Neurol. 1996, 55:904-914.
104. Fernandes de Abreu D.A., Ibrahim E.C., Boucraut J., Khrestchatisky M., Feron F. Severity of experimental autoimmune encephalomyelitis is unexpectedly reduced in mice born to vitamin D-deficient mothers. J. Steroid Biochem. Mol. Biol. 2010.
105. Sayeed I., Stein D.G. Progesterone as a neuroprotective factor in traumatic and ischemic brain injury. Prog. Brain Res. 2009, 175:219-237.
106. Cekic M., Sayeed I., Stein D.G. Combination treatment with progesterone and vitamin D hormone may be more effective than monotherapy for nervous system injury and disease. Front. Neuroendocrinol. 2009, 30:158-172.
107. Atif F., Sayeed I., Ishrat T., Stein D.G. Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone. Mol. Med. 2009, 15:328-336.
108. Garcion E., Sindji L., Montero-Menei C., Andre C., Brachet P., Darcy F. Expression of inducible nitric oxide synthase during rat brain inflammation: regulation by 1,25-dihydroxyvitamin D3. Glia 1998, 22:282-294.
109. Siegel A., Malkowitz L., Moskovits M.J., Christakos S. Administration of 1,25-dihydroxyvitamin D3 results in the elevation of hippocampal seizure threshold levels in rats. Brain Res. 1984, 298:125-129.
110. Kalueff A.V., Minasyan A., Tuohimaa P. Anticonvulsant effects of 1,25-dihydroxyvitamin D in chemically induced seizures in mice. Brain Res. Bull. 2005, 67:156-160.
111. Borowicz K.K., Morawska M., Furmanek-Karwowska K., Luszczki J.J., Czuczwar S.J. Cholecalciferol enhances the anticonvulsant effect of conventional antiepileptic drugs in the mouse model of maximal electroshock. Eur. J. Pharmacol. 2007, 573:111-115.
112. Kalueff A.V., Minasyan A., Keisala T., Kuuslahti M., Miettinen S., Tuohimaa P. Increased severity of chemically induced seizures in mice with partially deleted Vitamin D receptor gene. Neurosci. Lett. 2006, 394:69-73.
113. Caffrey J.M., Farach-Carson M.C. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J. Biol. Chem. 1989, 264:20265-20274.
114. Janjoppi L., Katayama M.H., Scorza F.A., Folgueira M.A., Brentani M., Pansani A.P., et al. Expression of vitamin D receptor mRNA in the hippocampal formation of rats submitted to a model of temporal lobe epilepsy induced by pilocarpine. Brain Res. Bull. 2008, 76:480-484.
115. Mehrotra P., Marwaha R.K., Aneja S., Seth A., Singla B.M., Ashraf G., et al. Hypovitaminosis D and hypocalcemic seizures in infancy. Indian Pediatr. 2009.
116. Bergqvist A.G., Schall J.I., Stallings V.A. Vitamin D status in children with intractable epilepsy, and impact of the ketogenic diet. Epilepsia. 2007, 48:66-71.
117. Sonnenberg J., Luine V.N., Krey L.C., Christakos S. 1,25-Dihydroxyvitamin D3 treatment results in increased choline acetyltransferase activity in specific brain nuclei. Endocrinology 1986, 118:1433-1439.
118. Smith M.P., Fletcher-Turner A., Yurek D.M., Cass W.A. Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine. Neurochem. Res. 2006, 31:533-539.
119. Tekes K., Gyenge M., Folyovich A., Csaba G. Influence of neonatal vitamin A or vitamin D treatment on the concentration of biogenic amines and their metabolites in the adult rat brain. Horm. Metab. Res. 2009, 41:277-280.
120. Lieberherr M. Effects of vitamin D3 metabolites on cytosolic free calcium in confluent mouse osteoblasts. J. Biol. Chem. 1987, 262:13168-13173.
121. Ibi M., Sawada H., Nakanishi M., Kume T., Katsuki H., Kaneko S., et al. Protective effects of 1 alpha,25-(OH)(2)D-3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001, 40:761-771.
122. Brewer L.D., Thibault V., Chen K.C., Langub M.C., Landfield P.W., Porter N.M. Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons. J. Neurosci. 2001, 21:98-108.
123. Alexianu M.E., Robbins E., Carswell S., Appel S.H. 1Alpha, 25 dihydroxyvitamin D3-dependent up-regulation of calcium-binding proteins in motoneuron cells. J. Neurosci. Res. 1998, 51:58-66.
124. de Viragh P.A., Haglid K.G., Celio M.R. Parvalbumin increases in the caudate putamen of rats with vitamin D hypervitaminosis. Proc. Natl. Acad. Sci. USA 1989, 86:3887-3890.
125. Garcion E., Thanh X.D., Bled F., Teissier E., Dehouck M.P., Rigault F., et al. 1,25-Dihydroxyvitamin D3 regulates gamma 1 transpeptidase activity in rat brain. Neurosci. Lett. 1996, 216:183-186.
126. Kroncke K.D., Klotz L.O., Suschek C.V., Sies H. Comparing nitrosative versus oxidative stress toward zinc finger-dependent transcription. Unique role for NO. J. Biol. Chem. 2002, 277:13294-13301.
127. Korsching S., Auburger G., Heumann R., Scott J., Thoenen H. Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. Embo J. 1985, 4:1389-1393.
128. Neveu I., Naveilhan P., Jehan F., Baudet C., Wion D., De Luca H.F., et al. 1,25-Dihydroxyvitamin D3 regulates the synthesis of nerve growth factor in primary cultures of glial cells. Brain Res. Mol. Brain Res. 1994, 24:70-76.
129. Wion D., MacGrogan D., Neveu I., Jehan F., Houlgatte R., Brachet P. 1,25-Dihydroxyvitamin D3 is a potent inducer of nerve growth factor synthesis. J. Neurosci. Res. 1991, 28:110-114.
130. Chao M.V., Hempstead B.L. p75 and Trk: a two-receptor system. Trends Neurosci. 1995, 18:321-326.
131. Naveilhan P., Neveu I., Baudet C., Funakoshi H., Wion D., Brachet P., et al. 1,25-Dihydroxyvitamin D3 regulates the expression of the low-affinity neurotrophin receptor. Brain Res. Mol. Brain Res. 1996, 41:259-268.
132. Chao M.V. The p75 neurotrophin receptor. J. Neurobiol. 1994, 25:1373-1385.
133. Saporito M.S., Wilcox H.M., Hartpence K.C., Lewis M.E., Vaught J.L., Carswell S. Pharmacological induction of nerve growth factor mRNA in adult rat brain. Exp. Neurol. 1993, 123:295-302.
134. Neveu I., Naveilhan P., Baudet C., Brachet P., Metsis M. 1,25-Dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes. Neuroreport 1994, 6:124-126.
135. Naveilhan P., Neveu I., Wion D., Brachet P. 1,25-Dihydroxyvitamin D3, an inducer of glial cell line-derived neurotrophic factor. Neuroreport 1996, 7:2171-2175.
136. Remy S., Naveilhan P., Brachet P., Neveu I. Differential regulation of GDNF, neurturin, and their receptors in primary cultures of rat glial cells. J. Neurosci. Res. 2001, 64:242-251.
137. Granholm A.C., Reyland M., Albeck D., Sanders L., Gerhardt G., Hoernig G., et al. Glial cell line-derived neurotrophic factor is essential for postnatal survival of midbrain dopamine neurons. J. Neurosci. 2000, 20:3182-3190.
138. Oo T.F., Burke R.E. The time course of developmental cell death in phenotypically defined dopaminergic neurons of the substantia nigra. Brain Res. Dev. Brain Res. 1997, 98:191-196.
139. Quintero E.M., Willis L.M., Zaman V., Lee J., Boger H.A., Tomac A., et al. Glial cell line-derived neurotrophic factor is essential for neuronal survival in the locus coeruleus-hippocampal noradrenergic pathway. Neuroscience 2004, 124:137-146.
140. Sapolsky R.M. Stress, glucocorticoids, and damage to the nervous system: the current state of confusion. Stress 1996, 1:1-19.
141. Chen T.L., Cone C.M., Morey-Holton E., Feldman D. Glucocorticoid regulation of 1,25(OH)2-vitamin D3 receptors in cultured mouse bone cells. J. Biol. Chem. 1982, 257:13564-13569.
142. Chen T.L., Cone C.M., Morey-Holton E., Feldman D. 1 Alpha,25-dihydroxyvitamin D3 receptors in cultured rat osteoblast-like cells. Glucocorticoid treatment increases receptor content. J. Biol. Chem. 1983, 258:4350-4355.
143. Massaro E.R., Simpson R.U., DeLuca H.F. Stimulation of specific 1,25-dihydroxyvitamin D3 binding protein in cultured postnatal rat intestine by hydrocortisone. J. Biol. Chem. 1982, 257:13736-13739.
144. Neveu I., Barbot N., Jehan F., Wion D., Brachet P. Antagonistic effects of dexamethasone and 1,25-dihydroxyvitamin D3 on the synthesis of nerve growth factor. Mol. Cell Endocrinol. 1991, 78:R1-R6.
145. Neveu I., Jehan F., Wion D. Alteration in the levels of 1,25-(OH)2D3 and corticosterone found in experimental diabetes reduces nerve growth factor (NGF) gene expression in vitro. Life Sci. 1992, 50:1769-1772.
146. Obradovic D., Gronemeyer H., Lutz B., Rein T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J. Neurochem. 2006, 96:500-509.
147. Torrey E.F., Miller J., Rawlings R., Yolken R.H. Seasonality of births in schizophrenia and bipolar disorder: a review of the literature. Schizophr. Res. 1997, 28:1-38.
148. Saha S., Chant D.C., Welham J.L., McGrath J.J. The incidence and prevalence of schizophrenia varies with latitude. Acta Psychiatr. Scand. 2006, 114:36-39.
149. Davies G., Welham J., Chant D., Torrey E.F., McGrath J. A systematic review and meta-analysis of Northern Hemisphere season of birth studies in schizophrenia. Schizophr. Bull. 2003, 29:587-593.
150. Cantor-Graae E., Selten J.P. Schizophrenia and migration: a meta-analysis and review. Am. J. Psychiatry 2005, 162:12-24.
151. Holick M.F. Environmental factors that influence the cutaneous production of vitamin D. Am. J. Clin. Nutr. 1995, 61:S638-S645.
152. Berg A.O., Melle I., Torjesen P.A., Lien L., Hauff E., Andreassen O.A. A cross-sectional study of vitamin D deficiency among immigrants and Norwegians with psychosis compared to the general population. J. Clin. Psychiatry 2010.
153. McGrath J., Saari K., Hakko H., Jokelainen J., Jones P., Jarvelin M.R., et al. Vitamin D supplementation during the first year of life and risk of schizophrenia: a Finnish birth cohort study. Schizophr. Res. 2004, 67:237-245.
154. McGrath J., Eyles D., Mowry B., Yolken R., Buka S. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr. Res. 2003, 63:73-78.
155. McGrath J.J., Eyles D.W., Pedersen C.B., Anderson C., Ko P., Burne T.H., et al. Neonatal vitamin D status and risk of schizophrenia: a population-based case-control study. Arch. Gen. Psychiatry 2010, In press.
156. Harrison P.J., Weinberger D.R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol. Psychiatry 2005, 10:40-68. image 45.
157. Laruelle M., Frankle W.G., Narendran R., Kegeles L.S., Abi-Dargham A. Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonism to glutamate NMDA facilitation. Clin. Ther. 2005, 27(Suppl. A):S16-S24.
158. Kathmann N., von Recum S., Haag C., Engel R.R. Electrophysiological evidence for reduced latent inhibition in schizophrenic patients. Schizophr. Res. 2000, 45:103-114.
159. Hedelin M., Lof M., Olsson M., Lewander T., Nilsson B., Hultman C.M., et al. Dietary intake of fish, omega-3, omega-6 polyunsaturated fatty acids and vitamin D and the prevalence of psychotic-like symptoms in a cohort of 33 000 women from the general population. BMC Psychiatry 2010, 10:38.
160. McGrath J. Is it time to trial vitamin D supplements for the prevention of schizophrenia?. Acta Psychiatr. Scand. 2010, In press.
161. Stumpf W.E., Privette T.H. Light, vitamin D and psychiatry. Role of 1,25 dihydroxyvitamin D3 (soltriol) in etiology and therapy of seasonal affective disorder and other mental processes. Psychopharmacology (Berl.) 1989, 97:285-294.
162. Gloth F.M., Alam W., Hollis B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J. Nutr. Health Aging 1999, 3:5-7.
163. Lansdowne A.T., Provost S.C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl.) 1998, 135:319-323.
164. Partonen T., Vakkuri O., Lamberg-Allardt C., Lonnqvist J. Effects of bright light on sleepiness, melatonin, and 25-hydroxyvitamin D(3) in winter seasonal affective disorder. Biol. Psychiatry 1996, 39:865-872.
165. Jorde R., Waterloo K., Saleh F., Haug E., Svartberg J. Neuropsychological function in relation to serum parathyroid hormone and serum 25-hydroxyvitamin D levels: the Tromso study. J. Neurol. 2006, 253:464-470.
166. Wilkins C.H., Sheline Y.I., Roe C.M., Birge S.J., Morris J.C. Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am. J. Geriatr. Psychiatry 2006, 14:1032-1040.
167. Pan A., Lu L., Franco O.H., Yu Z., Li H., Lin X. Association between depressive symptoms and 25-hydroxyvitamin D in middle-aged and elderly Chinese. J. Affect. Disord. 2009, 118:240-243.
168. Nanri A., Mizoue T., Matsushita Y., Poudel-Tandukar K., Sato M., Ohta M., et al. Association between serum 25-hydroxyvitamin D and depressive symptoms in Japanese: analysis by survey season. Eur. J. Clin. Nutr. 2009, 63:1444-1447.
169. Hoogendijk W.J., Lips P., Dik M.G., Deeg D.J., Beekman A.T., Penninx B.W. Depression is associated with decreased 25-hydroxyvitamin D and increased parathyroid hormone levels in older adults. Arch. Gen. Psychiatry 2008, 65:508-512.
170. Milaneschi Y., Shardell M., Corsi A.M., Vazzana R., Bandinelli S., Guralnik J.M., et al. Serum 25-hydroxyvitamin D and depressive symptoms in older women and men. J. Clin. Endocrinol. Metab. 2010, 95.
171. Bertone-Johnson E.R. Vitamin D and the occurrence of depression: causal association or circumstantial evidence?. Nutr. Rev. 2009, 67:481-492.
172. Young S.N. Has the time come for clinical trials on the antidepressant effect of vitamin D?. J. Psychiatry Neurosci. 2009, 34:3.
173. Dumville J.C., Miles J.N., Porthouse J., Cockayne S., Saxon L., King C. Can vitamin D supplementation prevent winter-time blues? A randomised trial among older women. J. Nutr. Health Aging 2006, 10:151-153.
174. Przybelski R.J., Binkley N.C. Is vitamin D important for preserving cognition? A positive correlation of serum 25-hydroxyvitamin D concentration with cognitive function. Arch. Biochem. Biophys. 2007, 460:202-205.
175. Wilkins C.H., Birge S.J., Sheline Y.I., Morris J.C. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J. Nat. Med. Assoc. 2009, 101:349-354.
176. Llewellyn D.J., Langa K.M., Lang I.A. Serum 25-hydroxyvitamin D concentration and cognitive impairment. J. Geri. Psychiatry Neurol. 2009, 22:188-195.
177. Buell J.S., Scott T.M., Dawson-Hughes B., Dallal G.E., Rosenberg I.H., Folstein M.F., et al. Vitamin D is associated with cognitive function in elders receiving home health services. Js Gerontol. Series A. Biol. Sci. and Med. Sci. 2009, 64:888-895.
178. Buell J.S., Dawson-Hughes B., Scott T.M., Weiner D.E., Dallal G.E., Qui W.Q., et al. 25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services. Neurology 2010, 74:18-26.
179. Lee D.M., Tajar A., Ulubaev A., Pendleton N., O'Neill T.W., O'Connor D.B., et al. Association between 25-hydroxyvitamin D levels and cognitive performance in middle-aged and older European men. J. Neurol. Neurosurg. Psychiatry 2009, 80:722-729.
180. Cannell J.J. Autism and vitamin D. Med. Hypotheses 2008, 70:750-759.
181. Fernell E., Barnevik-Olsson M., Bagenholm G., Gillberg C., Gustafsson S., Saaf M. Serum levels of 25-hydroxyvitamin D in mothers of Swedish and of Somali origin who have children with and without autism. Acta Paediatr. 2010, 99:743-747.
182. Eyles D.W. Vitamin D and autism: does skin colour modify risk?. Acta Paediatr. 2010, 99:645-647.
183. Humble M.B., Gustafsson S., Bejerot S. Low serum levels of 25-hydroxyvitamin D (25-OHD) among psychiatric out-patients in Sweden: relations with season, age, ethnic origin and psychiatric diagnosis. J. Steroid Biochem. Mol. Biol. 2010.
184. Kinney D.K., Barch D.H., Chayka B., Napoleon S., Munir K.M. Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder?. Med. Hypotheses 2010, 74:102-106.
185. Buell J.S., Dawson-Hughes B. Vitamin D and neurocognitive dysfunction: preventing "D"ecline?. Mol. Aspects Med. 2008, 29:415-422.
186. Grant W.B. Does vitamin D reduce the risk of dementia?. J. Alzheimer's Dis. 2009, 17:151-159.
187. Vieth R., Bischoff-Ferrari H., Boucher B.J., Dawson-Hughes B., Garland C.F., Heaney R.P., et al. The urgent need to recommend an intake of vitamin D that is effective. Am. J. Clin. Nutr. 2007, 85:649-650.
188. Hollis B.W., Wagner C.L. Vitamin D deficiency during pregnancy: an ongoing epidemic. Am. J. Clin. Nutr. 2006, 84:273.
189. Hollis B.W., Wagner C.L. Nutritional vitamin D status during pregnancy: reasons for concern. Cmaj 2006, 174:1287-1290.